NCT05645887View on ClinicalTrials.gov

Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

February 29, 2024

Primary Completion Date

May 23, 2024

Study Completion Date

May 23, 2024

Conditions

Septic Shock

Interventions

DRUG

Human albumin

Human albumin from day 0 to 7 if serum albumin concentrations \<35g/l.

OTHER

Saline solution

Saline solution from day 0 to day 7.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Albimmune SL

INDUSTRY

NCT05645887 - Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure. | Biotech Hunter | Biotech Hunter